Rosen Law Firm Announces Key Deadline in Edwards Lifesciences Securities Class Action – Investors Urged to Act by December 13
New York — Investors who purchased securities from Edwards Lifesciences Corporation between February 6, 2024, and July 24, 2024, are potentially eligible for compensation, as announced by Rosen Law Firm, a global investor rights legal practice. The firm, which focuses on securities class actions and shareholder derivative litigation, has set a lead plaintiff deadline of December 13, 2024. Anyone who acquired shares in Edwards Lifesciences during the said period might take part in the class action lawsuit without any out-of-pocket fees, as the costs are covered by a contingency fee arrangement. Those interested in joining … Read more